PubRank
Search
About
S A Glynn
Author PubWeight™ 23.26
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)
Hepatology
2000
2.30
2
Knowledge of HIV/AIDS transmission and screening in United States blood donors.
Transfusion
2001
2.20
3
First year donation patterns predict long-term commitment for first-time donors.
Vox Sang
2005
2.18
4
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.
Transfusion
2005
1.60
5
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.
Transfusion
2003
1.47
6
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.
J Infect Dis
1997
1.28
7
First-time blood donors: demographic trends.
Transfusion
2001
1.23
8
Do blood donors read and understand screening educational materials?
Transfusion
2003
1.22
9
Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.
Transfusion
2004
1.15
10
MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.
Oncogene
2012
1.13
11
Incidence rates of viral infections among repeat donors:are frequent donors safer?
Transfusion
2001
1.07
12
Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.
Arch Intern Med
1999
1.03
13
Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
Transfusion
2005
0.98
14
Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
Transfusion
2005
0.81
15
Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
Anticancer Res
2007
0.76
16
Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.
Transfusion
1997
0.76
17
Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis.
JAMA
2001
0.76
18
The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance.
Br J Cancer
2013
0.75
19
Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation site.
Transfusion
2003
0.75